US Patent Issued to Azitra on April 21 for "Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes" (Connecticut, Texas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,610, issued on April 21, was assigned to Azitra Inc (Branford, Conn.).

"Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes" was invented by Travis Michael Whitfill (Dallas) and Azim Momin Munivar (New Haven, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides, inter alia, engineered microbes expressing recombinant LEKTI domains that are effective to treat or ameliorate the symptoms of Netherton Syndrome. In certain embodiments, compositions, methods, and kits are provided comprising LEKTI domain expressing microbes."

The patent was filed on Aug. 16, 2023, under A...